GL1X · GenesisL1 explorer

Research workbench

Human PFKFB3 in complex with an indole inhibitor 2

Analyse Human PFKFB3 in complex with an indole inhibitor 2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5AJW
Type
protein
Length
439 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.5
Source
HOMO SAPIENS
Molecule
6-phosphofructo-2-KINASE/FRUCTOSE-2,6-bisphosphatase 3
EC
2.7.1.105, 3.1.3.46
UniProt
Q16875
Ligands
PHS, S6L, F6P, PO4
Pockets
4 · best druggability 0.78

Structure

x-ray diffraction · resolution 2.5 · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A6-phosphofructo-2-KINASE/FRUCTOSE-2,6-bisphosphatase 3 (EC 2.7.1.105, 3.1.3.46)protein43943% helix, 17% strandQ16875

Ligands and binding sites

  • PHS · Phosphonic acid · ligand · chains A
  • S6L · 2-amino-N-[4-(2-amino-1-benzyl-3-cyano-indol-5-yl)oxyphenyl]acetamide · ligand · chains A
  • F6P · 6-O-phosphono-beta-D-fructofuranose · sugar · chains A
  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13670.780.8844PO4
21650.730.9133PHS, F6P
33060.680.8338S6L
4600.300.7518empty

Compared structures

  • 5AJW · Human PFKFB3 in complex with an indole inhibitor 2 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16875 · AlphaFold monomer V2.0 prediction for 6-phosphofructo-2-KINASE/FRUCTOSE-2,6-bisphosphatase… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.